Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

This China sector is ramping up

Share | "Are you sure this is one of the top hospitals in Beijing? The paint's peeling!" This was my reaction after spending five minutes in a Chinese hospital. I asked our associate to do his best to snap some pictures without anyone noticing. (When your...
Larsen Kusick | October 28, 2012 |

Delivering innovative remote patient monitoring

Welcome to the Market Herald Video Q&A Podcast. I’m Brieanna McCutcheon. Cloud DX is emerging as the partner of choice among the largest global medical technology companies to provide innovative, best-in-class remote patient monitoring (RPM) solu...
Brieanna McCutcheon | September 22, 2022 |

Reliq Re-establishes Itself as Community Care Technology Leader ...

Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes A shift in the industry leads to big new contracts and parabolic stock performance for this small cap. A sweeping new development in what federal...
Streetwise Reports | November 14, 2019 |

Coronavirus Propels Telemedicine into the Spotlight

Summary: Coronavirus could be the game changer that propels telemedicine into the mainstream. Virtual clinical services have been around since the '90s but had failed to catch on. Now, a concerted effort by healthcare providers, insurance companies, the federal government...
Streetwise Reports | March 27, 2020 |

US between Scylla and Charybdis

I’m just going to come right out and say it: The United States is not equipped to deal with a pandemic. The nation of 327 million, despite having the number one economy in the world, and by far the most powerful military, is shockingly ill-prepared, not only ...
Richard (Rick) Mills | March 31, 2020 |

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report. In an Aug. 20 research note, analyst Ed Arce reported that H.C. Wainwright & Co. raised its target price on Nabriva Therapeutics Plc (NBRV:NASDAQ) to $8 per sh...
Streetwise Reports | August 28, 2019 |

Total SA Institutes Action Plan for $30/Barrel Oil

Shares of Total SA traded 14% higher today after the firm reported that has implemented a company-wide action plan to address the sharp decrease in oil prices. Integrated oil and gas company Total S.A. (TOT:NYSE) , today announced its immediate action pla...
Streetwise Reports | March 24, 2020 |

T2 Biosystems Shares Nearly Double on Worldwide COVID-19 Testing License Deal

Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument. Diagnostic...
Streetwise Reports | March 26, 2020 |

CytoSorbents Shares Trade 20% Higher as FDA Grants CytoSorb EUA for COVID-19

Shares of CytoSorbents traded higher setting a new 52-week intraday high price after the company reported that the FDA granted emergency use authorization for CytoSorb for use in patients with COVID-19. Critical care immunotherapy company CytoSorbents Corp....
Streetwise Reports | April 14, 2020 |

Visionstate continues to launch WANDA in new markets

TMH: Visionstate is a growth-oriented company investing primarily in the Internet of Things, big data and analytics, and sustainability. The Edmonton-based tech firm’s proprietary smart technology now extends to a range of public facilities across a...
Brieanna McCutcheon | May 18, 2023 |
1 2 3 4 5 6 7 8